Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06247254 · ClinicalTrials.gov registry record · NA

Telehealth-Enhanced Assessment and Management

A NA study of Blood Pressure, sponsored by Wake Forest University Health Sciences.

Active
Registry status
NA
Development phase
86
Enrollment target
1
Study location

NCT06247254 is a NA study of Blood Pressure that is active but no longer recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 86 participants, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06247254, a NA study of Blood Pressure, is active but no longer recruiting, sponsored by Wake Forest University Health Sciences.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
86 participants
Enrollment target
1
Study location

Study Summary

TEAMS-BP is a Patient-Centered Outcomes Research Institute (PCORI)-funded trial under the Phased Large Awards for Comparative Effectiveness Research (PLACER) funding mechanism to evaluate two comprehensive and evidence-based strategies for managing blood pressure (BP) following stroke.

Conditions Studied

Interventions

  • BEHAVIORAL Intensive Clinic Management
  • BEHAVIORAL Intensive Tailored Telehealth Management

Study Locations (1)

North Carolina

  • Wake Forest University Health Sciences - Winston-Salem

Trial Details

FieldValue
Enrollment Target 86 participants
Start Date 2024-11-15
Est. Completion 2028-07
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT06247254

The ClinicalTrials.gov registry entry for NCT06247254 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (70% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Blood Pressure appearing as the primary indexed condition, and to 2 interventions - of which Intensive Clinic Management is the first listed.

NCT06247254 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06247254 about?

NCT06247254 is a clinical study titled "Telehealth-Enhanced Assessment and Management". TEAMS-BP is a Patient-Centered Outcomes Research Institute (PCORI)-funded trial under the Phased Large Awards for Comparative Effectiveness Research (PLACER) funding mechanism to evaluate two comprehensive and evidence-based strategies for managing blood pressure (BP) following stroke.

What is the current status of trial NCT06247254?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 86 participants. The study started on 2024-11-15. Estimated completion is 2028-07.

What conditions does trial NCT06247254 study?

This clinical trial studies the following conditions: Blood Pressure.

What interventions are being tested in trial NCT06247254?

The interventions under investigation include: Intensive Clinic Management (BEHAVIORAL), Intensive Tailored Telehealth Management (BEHAVIORAL).

Who is sponsoring clinical trial NCT06247254?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06247254 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.